Fatality and interferon alpha for malignant melanoma

Lancet. 1998 Oct 31;352(9138):1443-4. doi: 10.1016/S0140-6736(05)61266-4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Fatal Outcome
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / adverse effects*
  • Male
  • Melanoma / therapy*
  • Middle Aged
  • Multiple Organ Failure / etiology*
  • Recombinant Proteins
  • Shock / etiology

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins